Cargando…

Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy

During the last decades, the pleiotropic antitumor functions exerted by type I interferons (IFNs) have become universally acknowledged, especially their role in mediating interactions between the tumor and the immune system. Indeed, type I IFNs are now appreciated as a critical component of dendriti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Medrano, Ruan F.V., Hunger, Aline, Mendonça, Samir Andrade, Barbuto, José Alexandre M., Strauss, Bryan E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642635/ https://www.ncbi.nlm.nih.gov/pubmed/29050360 http://dx.doi.org/10.18632/oncotarget.19531

Ejemplares similares

Harnessing combined p19Arf and interferon-beta gene transfer as an inducer of immunogenic cell death and mediator of cancer immunotherapy
por: Hunger, Aline, et al.
Publicado: (2017)

Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma()()
por: Catani, João Paulo Portela, et al.
Publicado: (2016)

Response of human melanoma cell lines to interferon-beta gene transfer mediated by a modified adenoviral vector
por: David, Taynah I. P., et al.
Publicado: (2020)

Combined p14ARF and Interferon-β Gene Transfer to the Human Melanoma Cell Line SK-MEL-147 Promotes Oncolysis and Immune Activation
por: Cerqueira, Otto Luiz Dutra, et al.
Publicado: (2020)

Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death
por: Hunger, Aline, et al.
Publicado: (2017)

Potentiation of combined p19Arf and interferon-beta cancer gene therapy through its association with doxorubicin chemotherapy
por: Medrano, Ruan F. V., et al.
Publicado: (2022)

Perspectives for cancer immunotherapy mediated by p19Arf plus interferon-beta gene transfer
por: Strauss, Bryan E, et al.
Publicado: (2018)

Type I Interferon Promotes Antitumor T Cell Response in CRPC by Regulating MDSC
por: Fan, Lilv, et al.
Publicado: (2021)

Immunomodulatory activity of interferon-beta
por: Kasper, Lloyd H, et al.
Publicado: (2014)

Antitumor Potential of Immunomodulatory Natural Products
por: Nuzzo, Genoveffa, et al.
Publicado: (2022)

Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation
por: Müller, Elisabeth, et al.
Publicado: (2018)

TRIMming Type I Interferon-Mediated Innate Immune Response in Antiviral and Antitumor Defense
por: Wang, Ling, et al.
Publicado: (2021)

Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies
por: Lutz, Emi A., et al.
Publicado: (2022)

Antitumoral and Immunomodulatory Effect of Mahonia aquifolium Extracts
por: Andreicuț, Andra Diana, et al.
Publicado: (2019)

Targeting intrinsic RIG-I signaling turns melanoma cells into type I interferon-releasing cellular antitumor vaccines
por: Bek, Sarah, et al.
Publicado: (2019)

Development of Kupffer cell targeting type-I interferon for the treatment of hepatitis via inducing anti-inflammatory and immunomodulatory actions
por: Minayoshi, Yuki, et al.
Publicado: (2018)

Immunomodulatory Role of Interferons in Viral and Bacterial Infections
por: Mertowska, Paulina, et al.
Publicado: (2023)

Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs
por: Zanoni, Ivan, et al.
Publicado: (2017)

Statins act as transient type I interferon inhibitors to enable the antitumor activity of modified vaccinia Ankara viral vectors
por: Tenesaca, Shirley, et al.
Publicado: (2021)

Type I interferon
por: Niewold, Timothy B.
Publicado: (2020)

The in vivo antitumor effects of type I-interferon against hepatocellular carcinoma: the suppression of tumor cell growth and angiogenesis
por: Enomoto, Hirayuki, et al.
Publicado: (2017)

Suppression of local type I interferon by gut microbiota–derived butyrate impairs antitumor effects of ionizing radiation
por: Yang, Kaiting, et al.
Publicado: (2021)

ILF3 contributes to the establishment of the antiviral type I interferon program
por: Watson, Samir F, et al.
Publicado: (2020)

Type I Interferon-Independent Dendritic Cell Priming and Antitumor T Cell Activation Induced by a Mycoplasma fermentans Lipopeptide
por: Takeda, Yohei, et al.
Publicado: (2018)

Type-I interferons in atherosclerosis
por: Chen, Hung-Jen, et al.
Publicado: (2019)

Antitumor and Immunomodulatory Effects of Polysaccharides from Broken-Spore of Ganoderma lucidum
por: Wang, Peng-Yun, et al.
Publicado: (2012)

Antitumor and Immunomodulatory Activities of Ganoderma lucidum Polysaccharides in Glioma-Bearing Rats
por: Wang, Chunhua, et al.
Publicado: (2018)

Amelioration of systemic antitumor immune responses in cocktail therapy by immunomodulatory nanozymes
por: Wang, Shuren, et al.
Publicado: (2022)

STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer
por: Vonderhaar, Emily P., et al.
Publicado: (2021)

Type I interferon, anti-interferon antibodies, and COVID-19
por: Calabrese, Leonard H, et al.
Publicado: (2021)

Type I and type III interferon in opposition?
por: Park, Matthew D.
Publicado: (2020)

The immunomodulatory anticancer agent, RRx-001, induces an interferon response through epigenetic induction of viral mimicry
por: Zhao, Hongjuan, et al.
Publicado: (2017)

Effect of Type-I Interferon on Retroviruses
por: Gómez-Lucía, Esperanza, et al.
Publicado: (2009)

Bunyaviruses and the Type I Interferon System
por: Elliott, Richard M., et al.
Publicado: (2009)

Overview of the biology of type I interferons
por: Kalliolias, George D, et al.
Publicado: (2010)

Type I interferon: friend or foe?
por: Trinchieri, Giorgio
Publicado: (2010)

Type I Interferon in Human Autoimmunity
por: Niewold, Timothy B.
Publicado: (2014)

Phleboviruses and the Type I Interferon Response
por: Wuerth, Jennifer Deborah, et al.
Publicado: (2016)

Type I Interferons and Cancer: An Evolving Story Demanding Novel Clinical Applications
por: Aricò, Eleonora, et al.
Publicado: (2019)

ATM inhibition augments type I interferon response and antitumor T-cell immunity when combined with radiation therapy in murine tumor models
por: Jin, Won Jong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lsk3hivv68d4tdoft4cu7j7889